These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26039103)

  • 1. Th2 cytokines inhibit lymphangiogenesis.
    Savetsky IL; Ghanta S; Gardenier JC; Torrisi JS; García Nores GD; Hespe GE; Nitti MD; Kataru RP; Mehrara BJ
    PLoS One; 2015; 10(6):e0126908. PubMed ID: 26039103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TH2 cells and their cytokines regulate formation and function of lymphatic vessels.
    Shin K; Kataru RP; Park HJ; Kwon BI; Kim TW; Hong YK; Lee SH
    Nat Commun; 2015 Feb; 6():6196. PubMed ID: 25648335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.
    Avraham T; Zampell JC; Yan A; Elhadad S; Weitman ES; Rockson SG; Bromberg J; Mehrara BJ
    FASEB J; 2013 Mar; 27(3):1114-26. PubMed ID: 23193171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
    Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
    Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair.
    Avraham T; Daluvoy S; Zampell J; Yan A; Haviv YS; Rockson SG; Mehrara BJ
    Am J Pathol; 2010 Dec; 177(6):3202-14. PubMed ID: 21056998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players.
    Ji RC
    Curr Med Chem; 2007; 14(22):2359-68. PubMed ID: 17896984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells.
    Karnezis T; Farnsworth RH; Harris NC; Williams SP; Caesar C; Byrne DJ; Herle P; Macheda ML; Shayan R; Zhang YF; Yazar S; Takouridis SJ; Gerard C; Fox SB; Achen MG; Stacker SA
    Cancer Res; 2019 Apr; 79(7):1558-1572. PubMed ID: 30709930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
    Lin T; Gong L
    Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory triggers of lymphangiogenesis.
    Mouta C; Heroult M
    Lymphat Res Biol; 2003; 1(3):201-18. PubMed ID: 15624438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-33 promotes inflammation-induced lymphangiogenesis via ST2/TRAF6-mediated Akt/eNOS/NO signalling pathway.
    Han L; Zhang M; Liang X; Jia X; Jia J; Zhao M; Fan Y
    Sci Rep; 2017 Sep; 7(1):10602. PubMed ID: 28878285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis.
    Maeng YS; Aguilar B; Choi SI; Kim EK
    Oncogene; 2016 Jan; 35(2):196-205. PubMed ID: 25772247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th2 Cytokines IL-4, IL-13, and IL-10 Promote Differentiation of Pro-Lymphatic Progenitors Derived from Bone Marrow Myeloid Precursors.
    Espinosa Gonzalez M; Volk-Draper L; Bhattarai N; Wilber A; Ran S
    Stem Cells Dev; 2022 Jun; 31(11-12):322-333. PubMed ID: 35442077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer.
    Xu J; Zhang C; He Y; Wu H; Wang Z; Song W; Li W; He W; Cai S; Zhan W
    Int J Cancer; 2012 Feb; 130(4):787-97. PubMed ID: 21387301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
    Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.
    Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Ngiwsara L; Svasti J; Koizumi K
    Vasc Med; 2018 Jun; 23(3):201-211. PubMed ID: 29629844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.
    Lee E; Rosca EV; Pandey NB; Popel AS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1812-21. PubMed ID: 21920451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.